Trials / No Longer Available
No Longer AvailableNCT00604643
Talent Aortic Cuff Stent Graft System Compassionate Use Registry
Compassionate Use of the TALENT Aortic Cuff in the Treatment of Patients Previously Treated With the AneuRx Stent Graft System With Sub-Optimal Stent Graft Outcomes
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Medtronic Cardiovascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
An evaluation of the TALENT Aortic Cuff in patients with existing AneuRx stent grafts who have experienced sub-optimal stent graft outcomes and are not deemed suitable candidates for treatment with an AneuRx Aortic Cuff.
Detailed description
The primary purpose of this registry is to provide an endovascular means of treatment for those patients experiencing a sub-optimal outcome related to the implanted AneuRx bifurcated stent graft and who are not deemed suitable candidates for treatment with an AneuRx Aortic Cuff. A sub-optimal outcome is defined as either a Type I or Type III endoleak and/or an inadequate seal zone (\< 1 cm). For Registry purposes, a Type III endoleak will be defined as a proximal modular endoleak.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | TALENT Aortic Cuff Abdominal Stent Graft | Endovascular Aneurysm Repair |
Timeline
- First posted
- 2008-01-30
- Last updated
- 2021-11-02
Locations
50 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00604643. Inclusion in this directory is not an endorsement.